22.08.2017 - Monsanto has signed a global licensing agreement with South Korean biotech ToolGen, gaining access to its CRISPR gene-editing technology. Financial terms were not disclosed. "This...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)